The IgM seroprevalence noted in both groups did not differ statistically, nevertheless, the IgG seroprevalence observed in MS patients was significantly higher compared to seroprevalence observed in blood donors (13.7% vs. 4.7%; χ21 = 7.03, p = 0.008). Here, CD40LG is linked to myeloid sarcoma.